Paclitaxel-Eluting Coronary Artery Stent - Vietnam Registration 2301007ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Paclitaxel-Eluting Coronary Artery Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2301007ĐKLH/BYT-HTTB and manufactured by Theo theo phụ lục.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Cardionovum GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2301007ĐKLH/BYT-HTTB
170000805/HSDKLH_NK_CD_K_QG-BYT
Theo theo phụ lục
Theo phụ lục
Technical Details
The Paclitaxel-coated stent angioplasty through the skin (TREAT) procedure is used to create a new blood vessel pathway (TREAT) in the coronary arteries with a blood vessel diameter from 2.0 mm to 4.0 mm to treat initial damage, restenosis in the stent (ISR), and small vessel disease (SVD).
Dates and Status
Sep 26, 2023